According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.

Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.

While Congress has protected labs from PAMA cuts via a series of one-year delays, this has locked lab prices at 2016 levels, ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...

The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

NEW YORK – Startup company Amplified Sciences on Monday said it has raised $2.6 million in a Series Seed Preferred round. The round was led by Elevate Ventures and OCA Ventures with participation from ...

NEW YORK – Roche subsidiary Foundation Medicine said on Monday that its FoundationOne Liquid CDx assay has received approval from the US Food and Drug Administration for use as a companion diagnostic ...

Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.